Enyo Pharma has successfully identified potential targets of its preclinical molecule series EYP002 with Charles River's technology.

HitGen has formed a drug discovery research collaboration with Boehringer Ingelheim to identify novel small-molecule leads.

Bay Area drug discovery company Verge Genomics has formed industry and academic alliances in neuro disorders.

CRO lobby group ACRO wants the government to drill down into what tax reform can mean for research.

Bioclinica is looking to broaden its reach with the purchase of MDDX Research & Informatics.

Major CRO player PPD has won a lucrative seven-year government contract in infectious disease.

Germany’s Evotec has penned another deal amid a stream of R&D pacts over the past year, this time with PARP player Tesaro.

Major CRO Parexel has teamed up with tech giant Microsoft to create a new cloud tech alliance, all aimed at speeding up drug research.

Forge Therapeutics and Evotec have launched a discovery platform to develop novel antibiotics targeting metalloenzymes.